Skip to main content
Equibles

MetLife Investment Management, LLC

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 1529735 Whippany, NJ
Back to ZVRA Full portfolio

Position in ZVRA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$495,102
+$250,219 QoQ
Shares Held
34,526
+31.4% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 158 holders
Holding Since
Jun 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZVRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. ZVRA ranks #123 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 402,605 $31,511,893
2 PRAX
Praxis Precision Medicines, Inc.
 90,543 $30,312,890
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 58,072 $28,846,104
4 FTRE
Fortrea Holdings Inc.
 1,362,169 $23,701,740
5 AXSM
Axsome Therapeutics, Inc.
 89,662 $21,946,567
6 IMNM
Immunome Inc.
 859,076 $18,203,820
7 REGN
Regeneron Pharmaceuticals, Inc.
 22,880 $14,266,595
8 CYTK
Cytokinetics Inc
 140,046 $11,930,518

All Filings in ZVRA

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $495,102 34,526
2026-03-31 $244,883 26,275
2025-12-31 $249,688 27,867
2025-09-30 $239,785 25,214
2025-06-30 $287,928 32,682
2025-03-31 $244,788 32,682
2024-12-31 $273,568 32,802
2024-09-30 $158,690 22,866
2024-06-30 $103,630 21,149
2024-03-31 $68,393 11,792
2023-12-31 $120,939 18,464
2023-09-30 $88,996 18,464
2023-06-30 $94,166 18,464
2021-09-30 $22,531 2,415
2021-06-30 $148,712 11,600